Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441142
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2007-02-27
Brief Title:
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
Sponsor:
Patrick Y Wen MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
06-377
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Patrick Y Wen MD
Lead Sponsor Class:
OTHER
Responsible Party:
Patrick Y Wen MD
Responsible Party Title:
Director Center For Neuro-Oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-FarberBrigham and Womens Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Henry Ford Hospital | OTHER |
| Dana-Farber Cancer Institute | OTHER |
| Beth Israel Deaconess Medical Center | OTHER |
| Massachusetts General Hospital | OTHER |
| University of Virginia | OTHER |
| Memorial Sloan Kettering Cancer Center | OTHER |